Lumida
/SNWV
⌘K
SANUWAVE Health Inc

SANUWAVE Health Inc

SNWV
$4.10USD+2.50%+0.10 today

MARKET CAP

35.3M

P/E (TTM)

12.4x

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$4
$41

AI Summary

Stalk
TrimMedium

In a Stage 4 decline, both medium- and long-term biases remain bearish. Despite an extreme oversold bounce, price is still below the downward-sloping 9/21 EMAs without any clear rejection at resistance levels. With no definitive short-side trigger, execution should be deferred, awaiting a pullback into the EMA zone for a structurally sound short entry.

  • UltraMist system taps growing wound care demand and rising consumable sales
  • Low debt supports sustained R&D and marketing investments
  • Q2 revenue $9.6–$9.8M fell 3–5% from prior year
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2025TREND
Sales, Adj.$44.1M
YoY %
P / Sales6.2x
EV / Sales6.7x
Gross Profit, Adj.$34.0M
YoY %
Margin %77.1%
EV / Gross Profit8.7x
EBITDA, Adj.$5.9M
YoY %
Margin %13.4%
EV / EBITDA49.8x
EBIT$4.9M
YoY %
Margin %11.2%
EV / EBIT59.6x
Net Income$11.8M
YoY %
Net Margin26.8%
EPS (GAAP)$0.41
YoY %